(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 5410.41 | 3912.84 | 38.27 | 5410.41 | 3912.84 | 38.27 | 16811.95 | 15545.35 | 8.15 |
| Other Income | 53.11 | 40.92 | 29.79 | 53.11 | 40.92 | 29.79 | 214.95 | 157.20 | 36.74 |
| PBIDT | 849.09 | 230.44 | 268.46 | 849.09 | 230.44 | 268.46 | 1335.74 | 1691.31 | -21.02 |
| Interest | 47.78 | 38.12 | 25.34 | 47.78 | 38.12 | 25.34 | 160.97 | 71.03 | 126.62 |
| PBDT | 801.31 | 192.32 | 316.65 | 801.31 | 192.32 | 316.65 | 1185.73 | 1620.28 | -26.82 |
| Depreciation | 79.79 | 78.79 | 1.27 | 79.79 | 78.79 | 1.27 | 293.08 | 244.42 | 19.91 |
| PBT | 721.52 | 113.53 | 535.53 | 721.52 | 113.53 | 535.53 | 892.65 | 1375.86 | -35.12 |
| TAX | 181.53 | 32.92 | 451.43 | 181.53 | 32.92 | 451.43 | 232.07 | 360.10 | -35.55 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 84.92 | 47.27 | 79.65 |
| PAT | 539.99 | 80.61 | 569.88 | 539.99 | 80.61 | 569.88 | 660.58 | 1015.76 | -34.97 |
| Equity | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 |
| PBIDTM(%) | 15.69 | 5.89 | 166.48 | 15.69 | 5.89 | 166.48 | 7.95 | 10.88 | -26.97 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1949.00 |
| Dr. Reddys Labs. | 1172.00 |
| Cipla | 1472.00 |
| Lupin | 2360.00 |
| Zydus Lifesciences | 1115.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: